Company intelligence / Profile preview

Biolytix

Witterswil, Solothurn, Switzerland

Ownership: Private
Employees: ~25
Development stage: Other

Overview

Biolytix is a Swiss-based contract research organization (CRO) specializing in molecular biology and microbiological analysis. Founded in 1998, the company provides a wide range of services including PCR-based testing, next-generation sequencing (NGS), and bioanalytical support for the pharmaceutical, food, and environmental sectors. Biolytix is particularly recognized for its expertise in GMO detection, pathogen identification, and pharmaceutical quality control. In 2019, the company was acquired by the GBA Group, expanding its reach within the European bioanalytical market. It operates under ISO 17025 accreditation and GMP/GLP standards to support drug development and food safety.

Modalities: BiologicSmall moleculeVaccine
Industry: Contract Research Organization

Beyond the preview

Go deeper on Biolytix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biolytix.

Explore the full profile